RESPONSE TO COMMENT ON TANG ET AL. Effects of insulin glargine and liraglutide therapy on liver fat as measured by magnetic resonance in patients with type 2 diabetes: A randomized trial. Diabetes care 2015;38:1339-1346

Diabetes Care

Volumn 38, Issue 9, 2015, Pages e150-e151

  Tang, An ^a   Rabasa Lhoret, Ŕemi ^a,b   Castel, Helene ^a   Wartelle Bladou, Claire ^a   Gilbert, Guillaume ^a,c   Massicotte Tisluck, Karine ^a   Chartrand, Gabriel ^a   E, Damien Olivi ^a   Julien, Anne Sophie ^d   De Guise, Jacques ^a   Soulez, Gilles ^a   Chiasson, Jean Louis ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c Philips Helthcare Canada   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN GLARGINE; LIRAGLUTIDE; ANTIDIABETIC AGENT;

DRUG EFFECT; FAT CONTENT; FATTY LIVER; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; TREATMENT DURATION; WAIST CIRCUMFERENCE; WEIGHT CHANGE; ADIPOSE TISSUE; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; FEMALE; LIVER; MALE;

ADIPOSE TISSUE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN GLARGINE; LIRAGLUTIDE; LIVER; MAGNETIC RESONANCE IMAGING; MALE;

EID: 84956596110     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-1091     Document Type: Note

References (5)

1. Shan P-F, Ji X-l, Wang L, Li P, Ren Y-Z. Comment on Tang et al. Effects of insulin glargine and liraglutide therapy on liver fat as measured by magnetic resonance in patients with type 2 diabetes: a randomized trial. Diabetes Care 2015;38:1339-1346 (Letter). Diabetes Care 2015;38:e148-e149. DOI:10.2337/dc15-0887.
2. Tang A, Rabasa-Lhoret R, Castel H, et al. Effects of insulin glargine and liraglutide therapy on liver fat as measured by magnetic resonance in patients with type 2 diabetes: a randomized trial. Diabetes Care 2015;38:1339-1346.
3. Lingvay I, Raskin P, Szczepaniak LS. Effect of insulin-metformin combination on hepatic steatosis in patients with type 2 diabetes. J Diabetes Complications 2007;21:137-142.
4. Juurinen L, Tiikkainen M, Häkkinen AM, Hakkarainen A, Yki-Järvinen H. Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes. Am J Physiol Endocrinol Metab 2007;292:E829- E835.
5. Tang A, Tan J, Sun M, et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 2013;267:422-431.